Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

The Isolation, Culture, and Propagation of Murine Intestinal Enteroids for the Study of Dietary Lipid Metabolism.

Li D, Dong H, Kohan AB.

Methods Mol Biol. 2017 Sep 20. doi: 10.1007/7651_2017_69. [Epub ahead of print]

PMID:
28929461
2.

VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.

Botteri G, Montori M, Gumà A, Pizarro J, Cedó L, Escolà-Gil JC, Li D, Barroso E, Palomer X, Kohan AB, Vázquez-Carrera M.

Diabetologia. 2017 Nov;60(11):2262-2273. doi: 10.1007/s00125-017-4401-5. Epub 2017 Aug 23.

3.

Key differences between apoC-III regulation and expression in intestine and liver.

West G, Rodia C, Li D, Johnson Z, Dong H, Kohan AB.

Biochem Biophys Res Commun. 2017 Sep 23;491(3):747-753. doi: 10.1016/j.bbrc.2017.07.116. Epub 2017 Jul 21.

4.

Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine.

Jattan J, Rodia C, Li D, Diakhate A, Dong H, Bataille A, Shroyer NF, Kohan AB.

J Lipid Res. 2017 May;58(5):853-865. doi: 10.1194/jlr.M071340. Epub 2017 Feb 3.

5.

Monosodium glutamate inhibits the lymphatic transport of lipids in the rat.

Kohan AB, Yang Q, Xu M, Lee D, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2016 Oct 1;311(4):G648-G654. doi: 10.1152/ajpgi.00342.2014. Epub 2016 Aug 11.

6.

Postprandial lymphatic pump function after a high-fat meal: a characterization of contractility, flow, and viscosity.

Kassis T, Yarlagadda SC, Kohan AB, Tso P, Breedveld V, Dixon JB.

Am J Physiol Gastrointest Liver Physiol. 2016 May 15;310(10):G776-89. doi: 10.1152/ajpgi.00318.2015. Epub 2016 Mar 11.

7.

Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight.

Wang F, Yoder SM, Yang Q, Kohan AB, Kindel TL, Wang J, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2015 Nov 15;309(10):G807-15. doi: 10.1152/ajpgi.00351.2013. Epub 2015 Sep 3.

8.

Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.

Kohan AB.

Curr Opin Endocrinol Diabetes Obes. 2015 Apr;22(2):119-25. doi: 10.1097/MED.0000000000000136. Review.

9.

Apolipoprotein A-IV: a protein intimately involved in metabolism.

Wang F, Kohan AB, Lo CM, Liu M, Howles P, Tso P.

J Lipid Res. 2015 Aug;56(8):1403-18. doi: 10.1194/jlr.R052753. Epub 2015 Feb 1. Review.

10.

ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety.

Kohan AB, Wang F, Lo CM, Liu M, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2015 Mar 15;308(6):G472-81. doi: 10.1152/ajpgi.00098.2014. Epub 2015 Jan 15. Review.

11.

Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph.

Wang F, Kohan AB, Dong HH, Yang Q, Xu M, Huesman S, Lou D, Hui DY, Tso P.

Physiol Rep. 2014 Mar 20;2(3):e00247. doi: 10.1002/phy2.247. Print 2014.

12.

GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat.

Ohlsson L, Kohan AB, Tso P, Ahrén B.

Regul Pept. 2014 Feb 10;189:40-5. doi: 10.1016/j.regpep.2014.02.001. Epub 2014 Feb 28.

13.

Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.

Li X, Xu M, Wang F, Kohan AB, Haas MK, Yang Q, Lou D, Obici S, Davidson WS, Tso P.

J Biol Chem. 2014 Jan 24;289(4):2396-404. doi: 10.1074/jbc.M113.511766. Epub 2013 Dec 5.

14.

Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride?

Kohan AB, Wang F, Li X, Vandersall AE, Huesman S, Xu M, Yang Q, Lou D, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2013 Jun 15;304(12):G1128-35. doi: 10.1152/ajpgi.00409.2012. Epub 2013 Apr 18.

15.

Serine arginine splicing factor 3 is involved in enhanced splicing of glucose-6-phosphate dehydrogenase RNA in response to nutrients and hormones in liver.

Walsh CM, Suchanek AL, Cyphert TJ, Kohan AB, Szeszel-Fedorowicz W, Salati LM.

J Biol Chem. 2013 Jan 25;288(4):2816-28. doi: 10.1074/jbc.M112.410803. Epub 2012 Dec 11.

16.

Dual-channel in-situ optical imaging system for quantifying lipid uptake and lymphatic pump function.

Kassis T, Kohan AB, Weiler MJ, Nipper ME, Cornelius R, Tso P, Dixon JB.

J Biomed Opt. 2012 Aug;17(8):086005. doi: 10.1117/1.JBO.17.8.086005.

17.

Methods for studying rodent intestinal lipoprotein production and metabolism.

Kohan AB, Howles PN, Tso P.

Curr Protoc Mouse Biol. 2012 Sep 1;2:219-230.

18.

The transport of DDT from chylomicrons to adipocytes does not mimic triacylglycerol transport.

Kohan AB, Vandersall AE, Yang Q, Xu M, Jandacek RJ, Tso P.

Biochim Biophys Acta. 2013 Feb;1831(2):300-5. doi: 10.1016/j.bbalip.2012.07.020. Epub 2012 Aug 3.

19.

Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.

Cyphert HA, Ge X, Kohan AB, Salati LM, Zhang Y, Hillgartner FB.

J Biol Chem. 2012 Jul 20;287(30):25123-38. doi: 10.1074/jbc.M112.375907. Epub 2012 Jun 1.

20.

Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion.

Wang F, Kohan AB, Kindel TL, Corbin KL, Nunemaker CS, Obici S, Woods SC, Davidson WS, Tso P.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9641-6. doi: 10.1073/pnas.1201433109. Epub 2012 May 22.

Supplemental Content

Loading ...
Support Center